Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence

NCT02566928 is registered in ClinicalTrials.gov with Clinical Directors Network as lead sponsor.

NCT NCT02566928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02566928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
Lead sponsor
Clinical Directors Network
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2015
Completion date
December 31, 2018
Enrollment
278 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistance, methicillin-resistant staphylococcus aureus, recurrence, staphylococcal skin infections